BR9708443B1 - vacina contra a sÍndrome reprodutiva e respiratària em porcinos. - Google Patents

vacina contra a sÍndrome reprodutiva e respiratària em porcinos.

Info

Publication number
BR9708443B1
BR9708443B1 BRPI9708443-3A BR9708443A BR9708443B1 BR 9708443 B1 BR9708443 B1 BR 9708443B1 BR 9708443 A BR9708443 A BR 9708443A BR 9708443 B1 BR9708443 B1 BR 9708443B1
Authority
BR
Brazil
Prior art keywords
pigs
respiratory syndrome
vaccine against
against reproductive
reproductive
Prior art date
Application number
BRPI9708443-3A
Other languages
English (en)
Portuguese (pt)
Other versions
BR9708443A (pt
Inventor
Richard A Hesse
Norte Americana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24442410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9708443(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of BR9708443A publication Critical patent/BR9708443A/pt
Publication of BR9708443B1 publication Critical patent/BR9708443B1/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
BRPI9708443-3A 1996-03-01 1997-02-26 vacina contra a sÍndrome reprodutiva e respiratària em porcinos. BR9708443B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60980696A 1996-03-01 1996-03-01
PCT/US1997/002562 WO1997031651A1 (en) 1996-03-01 1997-02-26 Porcine reproductive and respiratory syndrome vaccine

Publications (2)

Publication Number Publication Date
BR9708443A BR9708443A (pt) 1999-08-03
BR9708443B1 true BR9708443B1 (pt) 2012-06-12

Family

ID=24442410

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9708443-3A BR9708443B1 (pt) 1996-03-01 1997-02-26 vacina contra a sÍndrome reprodutiva e respiratària em porcinos.

Country Status (19)

Country Link
EP (1) EP0894007A1 (es)
JP (1) JP3135069B2 (es)
KR (1) KR100297537B1 (es)
CN (1) CN1165342C (es)
AR (1) AR006023A1 (es)
AU (1) AU2277497A (es)
BG (1) BG64693B1 (es)
BR (1) BR9708443B1 (es)
CA (1) CA2248182C (es)
CO (1) CO4600644A1 (es)
CZ (1) CZ273798A3 (es)
EE (1) EE04741B1 (es)
HU (1) HUP9901958A3 (es)
MY (1) MY115070A (es)
PL (1) PL328627A1 (es)
RU (1) RU2187333C2 (es)
SK (1) SK119498A3 (es)
WO (1) WO1997031651A1 (es)
ZA (1) ZA971663B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839912A1 (en) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
NZ513289A (en) 1998-12-22 2003-04-29 Pfizer Prod Inc Infectious cDNA clone of north american procine reproductive and respiratory syndrome (PRRS) virus and uses thereof
CA2366072C (en) 1999-03-08 2007-07-10 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Prrsv vaccines
ES2348159T3 (es) 1999-04-22 2010-11-30 United States Department Of Agriculture Vacuna contra el sindrome respiratorio y reproductivo porcino basada en el aislado ja-142.
RU2007101725A (ru) 2004-06-18 2008-07-27 Риджентс Оф Дзе Юниверсити Оф Миннесота (Us) Идентификация инфицированных вирусом и вакцинированных вирусом организмов
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
CA2894069C (en) 2005-06-24 2019-02-26 Regents Of The University Of Minnesota Prrs viruses, infectious clones, mutants thereof, and methods of use
CN101612395B (zh) * 2008-06-24 2012-02-08 扬州优邦生物制药有限公司 一种培养敏感细胞生产蓝耳病疫苗的方法
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物
SG192821A1 (en) 2011-02-17 2013-09-30 Boehringer Ingelheim Vetmed Commercial scale process for production of prrsv
EA038012B1 (ru) 2011-02-17 2021-06-23 Бёрингер Ингельхайм Ветмедика Гмбх Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
EP2737058A1 (en) 2011-07-29 2014-06-04 Boehringer Ingelheim Vetmedica GmbH INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
KR101300528B1 (ko) * 2011-10-05 2013-09-02 캔 테크놀로지스 인코포레이티드 액티노바실러스 플루로뉴모니애 감염 방지 및 처치용 조성물
US9579373B2 (en) 2013-03-15 2017-02-28 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
CZ309704B6 (cs) * 2020-12-10 2023-08-09 Univerzita Palackého v Olomouci Transportní médium pro transport a skladování virů
EP4012025A1 (en) * 2020-12-10 2022-06-15 Univerzita Palackého v Olomouci Transport medium for samples containing nucleic acids and/or proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042830A (en) * 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
AU2684792A (en) * 1991-10-14 1993-05-21 Akzo Nobel N.V. Porcine reproductive respiratory syndrome vaccine and diagnostic
FR2686097B1 (fr) * 1992-01-14 1994-12-30 Rhone Merieux Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
ATE197314T1 (de) * 1993-02-08 2000-11-15 Bayer Ag Verfahren zum vermehren des das reproduktions- und atemwegs-syndrom verursachenden schweinevirus und dessen verwendung als impfstoff.
ES2074950B1 (es) * 1993-09-17 1996-03-16 Iberica Cyanamid Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
EP0676467B1 (en) * 1994-04-11 2001-10-04 Akzo Nobel N.V. European vaccine strains of the porcine reproductive respiratory syndrome virus (PRRSV)
US5690940A (en) * 1995-06-21 1997-11-25 Regents Of The University Of Minnesota Low pathogencity PRRS live virus vaccines and methods of preparation thereof

Also Published As

Publication number Publication date
JPH11506122A (ja) 1999-06-02
ZA971663B (en) 1997-08-26
CO4600644A1 (es) 1998-05-08
SK119498A3 (en) 1999-07-12
WO1997031651A1 (en) 1997-09-04
MX9807083A (es) 1998-12-31
JP3135069B2 (ja) 2001-02-13
CZ273798A3 (cs) 1999-02-17
EE04741B1 (et) 2006-12-15
KR19990087432A (ko) 1999-12-27
EP0894007A1 (en) 1999-02-03
AR006023A1 (es) 1999-07-21
AU2277497A (en) 1997-09-16
HUP9901958A3 (en) 2000-04-28
CA2248182C (en) 2004-04-20
BG102809A (en) 1999-05-31
KR100297537B1 (ko) 2001-10-26
CN1216922A (zh) 1999-05-19
HUP9901958A2 (hu) 1999-10-28
BG64693B1 (bg) 2005-12-30
CA2248182A1 (en) 1997-09-04
RU2187333C2 (ru) 2002-08-20
MY115070A (en) 2003-03-31
PL328627A1 (en) 1999-02-15
BR9708443A (pt) 1999-08-03
CN1165342C (zh) 2004-09-08
EE9800267A (et) 1999-02-15

Similar Documents

Publication Publication Date Title
BR9708443B1 (pt) vacina contra a sÍndrome reprodutiva e respiratària em porcinos.
ZA966776B (en) Device in inhalers.
DK102894A (da) Vaccine mod det porcine reproduktions- og respirationssyndrom
AU3512797A (en) Porcine reproductive and respiratory syndrome vaccine
EP0671658A3 (en) Exposure device and the associated reflection mask.
DE59200763D1 (de) Zange mit wahlweiser frontaler und seitlicher Einführung.
NL1010171A1 (nl) Reed-Solomon decoderingsinrichting en decoderingswerkwijze.
EP0972243A4 (en) POLYNOMIAL CALCULATOR AND RELATED METHOD
NL1007839A1 (nl) Formulering en gebruik.
IL128111A0 (en) An expression silencing system and different uses thereof
FI945931A (fi) Taipuisa, PVF3:een perustuva suojakuori ja sen käyttäminen metalliletkuissa
NL1001230C1 (nl) Voetsteun.
GB2296659B (en) An agent which increases the immune response in humans and animals
TR28784A (tr) Tampon calistirma basincinin düsürülmesi icin yöntem ve cihaz.
ES1027927Y (es) Almohada cervical perfeccionada.
KR960004409U (ko) 좌, 우 회전이 가능한 에어노즐
ES1027955Y (es) Almohada perfeccionada.
ES1027192Y (es) Almohada perfeccionada.
ES1027698Y (es) Almohadon perfeccionado.
ITBA940012V0 (it) Cannula modificata per lipoaspirazioni e aspirazioni in genere.
ES1027570Y (es) Maqueta perfeccionada.
ES1028527Y (es) Almohada cervical compuesta perfeccionada.
ES1028637Y (es) Dispositivo para accionamiento de reposapies en sillones.
BR7401666U (pt) Disposiçao introduzida em pá
KR950026534U (ko) 소편과 이를 이용한 자리

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/06/2012, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved
B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI-52400.061553/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132273-17.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU:OSI PHARMACEUTICALS, LLC , PFIZER, SANOFI-AVERTI, , SANOFI-AVERTI DEUTCHLAND GMBH, SCHERING CORPORATION.

B25G Requested change of headquarter approved
B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 26/02/2017, CONFORME DETERMINADO NO INPI-52400.061553/2013-52 SECAO JUDICIARIA DO RIO DE JANEIRO 9A VARA FEDERAL DO RIO DE JANEIRO PROCESSO : NO 0132273-17.2013.4.02.5101.

B21H Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 21.1 NA RPI NO 2543 DE 01/10/2019 POR TER SIDO INDEVIDA.

B19A Notification of judicial decision: notification of judicial decision

Free format text: INPI NO 52402.005802/2020-39 TRIBUNAL REGIONAL FEDERAL DA 2A REGIAO PROCESSO : NO 5004917-81.2020.4.02.0000/RJ REQUERENTE: MERCK SHARP AND DOHME CORPORATION REQUERENTE: PFIZER PRODUCTS REQUERENTE: OSI PHARMACEUTICALS, LLC. REQUERIDO: INPI-INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL MPF: MINISTERIO PUBLICO FEDERAL AMICUS CURIAE: ASSOCIACAO BRAS DAS IND DE Q FINA B E SUAS ESP ABIFINA AMICUS CURIAE: INTERFARMA ASSOCIACAO DA INDUSTRIA FARMACEUTICA DE PESQUISA INTERESSADO: SANOFI-AVENTIS DEUTSCHLAND GMBM INTERESSADO: SANOFI AVENTIS INTERESSADO: ZOETIS LLC DECISAO: ANTE O EXPOSTO, ATRIBUO EFEITO SUSPENSIVO A APELACAO INTERPOSTA NO PROCESSO NO 0132273-17.2013.4.02.5101 POR OSI PHARMA

B19A Notification of judicial decision: notification of judicial decision

Free format text: INPI NO 52400.061553/2013-52 NUP: 00848.000587/2019-11 (REF. 00408.129415/2017-38) INTERESSADOS: THE PROVOST FELLOWS AND SCHOLARS OF THE HOLY UNDIVIDED TRINITYOF QUEEN ELIZABETH NEAR DUBLIN E OUTROS DECISAO: ?EM FACE DO EXPOSTO, CONCEDO A TUTELA PROVISORIA POSTULADA PARA DETERMINAR O EFEITO SUSPENSIVO AO RECURSO ESPECIAL, MANTENDO A VIGENCIA DAS PATENTES TIPO MAILBOX CONCEDIDAS PELO INPI, CONFORME O ENTENDIMENTO ANTERIOR, ATE POSTERIOR SOLUCAO DA CAUSA".